Drug
Prohema CB Transplant
Prohema CB Transplant: highest development phase Phase 1, developed by Fate Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Fate Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| ProHema-CB Transplant NCT02354443 | Phase 1 | Metabolic Disorders |
Latest
No recent events.
Follow Prohema CB Transplant on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.